Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 196 of 5804
-
Could a new pill tame Autism-Related irritability in kids?
Symptom relief Not yet recruitingThe purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New hope for ovarian cancer: targeted drug combo takes on resistant tumors
Disease control Not yet recruitingThis phase II trial compares the effect of sacituzumab govitecan and bevacizumab to standard care (carboplatin, pegylated liposomal doxorubicin, and bevacizumab) in patients with ovarian cancer that has come back after an initial response to platinum therapy (platinum-sensitive),…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New pill targets Leukemia's genetic weakness in patients too sick for chemo
Disease control Not yet recruitingThis phase II trial tests how well ziftomenib works in treating patients with NPM1 mutated or KMT2A rearranged acute myeloid leukemia (AML) and are not eligible to receive standard therapy. AML is often due to genetic changes in the cancer cells, including mutations in the NPM1 g…
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Magic mushroom compound tested for OCD in small trial
Symptom relief Not yet recruitingPrevious research indicates that psilocybin, a drug that changes activity in brain areas believed to be involved in obsessive-compulsive disorder (OCD), might improve treatment for, and improve lives of, people diagnosed with OCD. The investigators propose to study 20 patients wi…
Phase: PHASE1, PHASE2 • Sponsor: Francisco A Moreno • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New drug cocktail targets tough pancreatic tumors
Disease control Not yet recruitingThis phase I/II trial tests the safety, side effects, best dose and how well giving selumetinib with DS-8201a works for the treatment of pancreatic ductal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New ER discharge plan aims to stop opioid overdose deaths
Disease control Not yet recruitingOpioid overdose deaths have reached historically high records in the United States and are particularly concentrated among patients after emergency department (ED) discharge. Evidence-based treatment modules to reduce repeat opioid overdose and mortality are lacking in this patie…
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to tame autoimmune hepatitis and cut steroid use
Disease control Not yet recruitingThe main objectives of this trial are to evaluate the safety and tolerability of inebilizumab in participants with autoimmune hepatitis (AIH) (Part 1) and to evaluate the efficacy of inebilizumab on AIH disease activity and glucocorticoid (GC) use in the management of AIH (Part 2…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Engineered herpes virus takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingVG2025 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection. This Phase I study will be conducted in herpes simplex virus (HSV) -seropositive subjects with advanced malignant solid tumors that are refractory to conventional therapies. This is an open label stud…
Phase: PHASE1, PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a smaller surgery spare medullary thyroid cancer patients from lifelong pills?
Disease control Not yet recruitingThis clinical trial studies how well thyroid lobectomy with ipsilateral central neck dissection works to treat medullary thyroid cancer (MTC) in patients without a germline RET mutation (sporadic). Currently, sporadic and germline RET (rearranged during transfection) mutation pos…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
First-of-its-kind online program aims to prevent sexual assault among trans undergraduates
Prevention Not yet recruitingThe purpose of this study is to adapt and pilot a sexual assault prevention intervention for transgender and nonbinary (trans) undergraduate students. Forty percent of trans individuals (i.e., individuals whose gender identity does not align with their sex assigned at birth, incl…
Phase: NA • Sponsor: Sarah Peitzmeier • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC
-
Can a tiny implant seal large artery holes faster and safer?
Disease control Not yet recruitingThe objective of this study is to establish reasonable assurance of safety and effectiveness for the xDot Access Management System (AMS) when used as indicated for femoral-arterial and femoral-venous closure. Additionally, this study will provide preliminary evidence on the impac…
Phase: NA • Sponsor: xDot Medical, Inc • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Gene therapy joins forces with chemo and immunotherapy to fight bladder cancer
Disease control Not yet recruitingThis phase II trial tests the effect of intravesical nadofaragene firadenovec in combination with gemcitabine, cisplatin and durvalumab before (neoadjuvant) radical cystectomy (RC) in treating patients with muscle invasive bladder cancer. The combination of gemcitabine, cisplatin…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New Self-Amplifying mRNA vaccine aims to better protect transplant patients against COVID-19
⭐️ VACCINE ⭐️ Not yet recruitingThis phase IIb trial compares the effect of LUNAR-COV19 vaccine to Comirnaty vaccine in treating adult patients who have received a hematopoietic cell transplant (HCT). Guidelines recommend repeating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination of 3 me…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:04 UTC
-
New MRI dye could spot brain tumors sooner in cancer patients
Diagnosis Not yet recruitingThe survival of patients with CNS metastases often remains limited to some months. CNS metastases are also associated with neurological decline and decrease of quality of life. An early identification of CNS metastases may potentially lead to more therapeutic options and prevent …
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New urine test aims to catch aggressive prostate cancer early
Diagnosis Not yet recruitingThis clinical trial tests how well a urine prostate cancer screening test, My Prostate Score 2 (MPS2), integrated with magnetic resonance imaging (MRI) works for early detection of prostate cancer. MPS2 is an investigational urine-based test designed to help identify the likeliho…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Could a 'Vaginal microbiome Transplant' stop recurring BV?
Disease control Not yet recruitingThe MOTIF@ FRESH trial will assess the safety and efficacy of "vaginal microbiome transplantation" (VMT). Healthy females will be enrolled to donate vaginal fluid which will be processed and transplanted in females with a history of recurrent bacterial vaginosis (BV), treated wit…
Phase: PHASE2 • Sponsor: Douglas Kwon • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for aggressive prostate cancer: carboplatin combo tested in phase 3 trial
Disease control Not yet recruitingThe current standard of patients with de novo metastatic hormone sensitive prostate cancer (mHSPC) is to offer androgen deprivation therapy (ADT) with androgen receptor pathway inhibitors (ARPI). In addition, upfront 6 cycles of docetaxel, if patient is eligible, and prostate rad…
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Brain-Spine bridge aims to restore movement after stroke
Disease control Recruiting nowThe purpose of this clinical study is to evaluate the preliminary safety and effectiveness of using a cortical recording device (ECoG) combined with cervical and lumbar targeted epidural electrical stimulation (EES) of the spinal cord to restore voluntary motor functions of upper…
Phase: NA • Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Sleep drug may boost PTSD therapy in veterans
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if combining suvorexant (a sleep medication) with a shorter form of prolonged exposure therapy called PE-PC works to treat PTSD symptoms and improve sleep in Veterans and military personnel with PTSD and insomnia, with and without mild-…
Phase: PHASE4 • Sponsor: Northern California Institute of Research and Education • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Scientists map brain changes during Hour-Long DMT experience
Knowledge-focused Not yet recruitingThis study examines how the psychedelic substance DMT affects the human brain when administered by the intravenous (IV) route. DMT is a naturally occurring chemical in the body that is thought to help improve mood when ingested in a continuously monitored medical setting. Previou…
Phase: PHASE1 • Sponsor: Jon Dean • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC